2 Unstoppable Growth Stocks to Buy in 2022 and Beyond
Let's look at two top stocks that have performed worse than the broader market this year: DexCom (NASDAQ: DXCM) and Microsoft (NASDAQ: MSFT). Shares of medical devices specialist DexCom have dropped by 39% year to date. DexCom's own G6 CGM system continues to be highly successful.